3 news items
Ligand and Agenus Enter Into $100 Million Royalty Financing Agreement
AGEN
LGND
7 May 24
in the metastatic, relapsed/refractory colorectal cancer setting, in addition to other major indications, including pancreatic cancer, lung cancer
Ligand Partner Eisai Receives Approval In Japan For Injection Formulation Of Antiepileptic Drug Fycompa
LGND
22 Feb 24
, and that Captisol is once again proving to be an invaluable building block in drug development by enabling a new formulation that will make a major difference
Ligand Partner Eisai Receives Approval in Japan for Injection Formulation of Antiepileptic Drug Fycompa®
LGND
22 Feb 24
by enabling a new formulation that will make a major difference in people's lives."
Ligand first entered
- Prev
- 1
- Next